Search Press releases Keywords From To 13 Dec 2022 UCB and Praxis Precision Medicines Announce Epilepsy Research Collaboration Read More 12 Dec 2022 Changes in UCB’s Board of Directors Read More 9 Dec 2022 UCB Announces Positive Phase 3 Studies for Bimekizumab in Hidradenitis Suppurativa Read More 7 Dec 2022 The Lancet Publishes Results from Two Bimekizumab Phase 3 Studies in Psoriatic Arthritis Read More 1 Dec 2022 UCB to present data at the American Epilepsy Society 76th Annual Meeting 2022 supporting a decades-long commitment to transforming epilepsy care Read More 22 Nov 2022 UCB Submits Response to FDA Complete Response Letter for Bimekizumab Read More Pagination First page Previous page Previous … Page 20 Page 21 Page 22 Page 23 Current page 24 Page 25 Page 26 Page 27 Page 28 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
